Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator

Cerebrovascular Diseases

Volumn 35, Issue 5, 2013, Pages 461-468

  Chung, Jong Won ^a   Kim, Kyeong Joon ^a   Noh, Won Young ^a   Jang, Myung Suk ^a   Yang, Mi Hwa ^a   Han, Moon Ku ^a   Kwon, O Ki ^b   Jung, Cheolkyu ^c   Kim, Jae Hyoung ^c   Oh, Chang Wan ^b   Lee, Ji Sung ^d   Lee, Juneyoung ^d   Bae, Hee Joon ^a  

^a Departments of Neurology   (South Korea)

^b Departments of Neurosurgery   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Acute stroke; Brain imaging; Combined thrombolysis; Fluid attenuated inversion recovery; Functional outcome; Infarct volume; Recanalization; Stroke treatment

Indexed keywords

ABCIXIMAB; BIOLOGICAL MARKER; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; FEMALE; FLUID ATTENUATED INVERSION RECOVERY MAGNETIC RESONANCE IMAGING; FOLLOW UP; HEMORRHAGIC TRANSFORMATION; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 84878352572     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000350201     Document Type: Article

References (33)

1. Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007; 38: 967-973.
2. Ibrahim MM, Sebastian J, Hussain M, Al-Hussain F, Uchino K, Molina C, Khan K, Demchuk AM, Alexandrov AV, Saqqur M: Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke Cerebrovasc Dis 2010; 30: 508-513.
3. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 2004; 35: 904-911.
4. Flaherty ML, Woo D, Kissela B, Jauch E, Pancioli A, Carrozzella J, Spilker J, Sekar P, Broderick J, Tomsick T: Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005; 64: 386-388.
5. Thomalla G, Rossbach P, Rosenkranz M, Siemonsen S, Krutzelmann A, Fiehler J, Gerloff C: Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009; 65: 724-732.
6. Thomalla G, Cheng B, Ebinger M, Hao Q, Tourdias T, Wu O, Kim JS, Breuer L, Singer OC, Warach S, Christensen S, Treszl A, Forkert ND, Galinovic I, Rosenkranz M, Engelhorn T, Kohrmann M, Endres M, Kang DW, Dousset V, Sorensen AG, Liebeskind DS, Fiebach JB, Fiehler J, Gerloff C: DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (pre-FLAIR). A multicentre observational study. Lancet Neurol 2011; 10: 978-986.
7. Lee BC, Roh JK: International experience in stroke registries: Korean stroke registry. Am J Prev Med 2006; 31:S243-S245.
8. Clinical Research Center for Stroke: Clinical practice guidelines for stroke. Clinical research center for stroke web site. http://www. Stroke-crc.Or.Kr/cpgs%20for%20stroke%20 (english).Pdf. Accessed January 3, 2011.
9. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF: Guidelines for the early management of adults with ischemic stroke. A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711.
10. Adams H, Adams R, Del Zoppo G, Goldstein LB: Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the stroke council of the American Heart Association/American Stroke Association. Stroke 2005; 36: 916-923.
11. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ: Guidelines for the early management of patients with ischemic stroke: A scientific statement from the stroke council of the American Stroke Association. Stroke 2003; 34: 1056-1083.
12. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke 1997; 28: 2109-2118.
13. Saver JL, Gornbein J, Starkman S: Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit. Stroke 2010; 41: 2381-2390.
14. Kay R, Wong KS, Perez G, Woo J: Dichotomizing stroke outcomes based on self-reported dependency. Neurology 1997; 49: 1694-1696.
15. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34:e109-e137.
16. Ernst R, Pancioli A, Tomsick T, Kissela B, Woo D, Kanter D, Jauch E, Carrozzella J, Spilker J, Broderick J: Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 2000; 31: 2552-2557.
17. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM: Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002; 50: 251-259.
18. Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO: Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008; 17: 121-128.
19. Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP: Methodology of the interventional management of stroke III trial. Int J Stroke 2008; 3: 130-137.
20. National Institute of Neurological Disorders and Stroke: Interventional management of stroke III trial. NINDS clinical trials web site. Http://www.Ninds.Nih.Gov/disorders/clinical-trials/ims-iii.Htm. Accessed July 4, 2012.
21. Rubiera M, Ribo M, Pagola J, Coscojuela P, Rodriguez-Luna D, Maisterra O, Ibarra B, Pineiro S, Meler P, Romero FJ, Alvarez-Sabin J, Molina CA: Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke 2011; 42: 993-997.
22. Mullen MT, Pisapia JM, Tilwa S, Messe SR, Stein SC: Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intraarterial, or combined intravenousarterial thrombolysis. Stroke 2012; 43: 2350-2355.
23. Abciximab Emergent Stroke Treatment Trial I: Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 2005; 36: 880-890.
24. Siebler M, Hennerici MG, Schneider D, von Reutern GM, Seitz RJ, Rother J, Witte OW, Hamann G, Junghans U, Villringer A, Fiebach JB: Safety of tirofiban in acute ischemic stroke. The SATIS trial. Stroke 2011; 42: 2388-2392.
25. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW: Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome A multivariable analysis. Stroke 2000; 31: 2597-2602.
26. Ebinger M, Galinovic I, Rozanski M, Brunecker P, Endres M, Fiebach JB: Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock Stroke 2010; 41: 250-255.
27. Perini F, De Boni A, Marcon M, Bolgan I, Pellizzari M, Dionisio LD: Systolic blood pressure contributes to intracerebral haemorrhage after thrombolysis for ischemic stroke. J Neurol Sci 2010; 297: 52-54.
28. Ko Y, Park JH, Yang MH, Ko SB, Han MK, Oh CW, Lee J, Bae HJ: The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke. Stroke 2010; 41: 2512-2518.
29. Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA: Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome. Cerebrovasc Dis 2012; 33: 135-140.
30. Vergouwen MD, Algra A, Pfefferkorn T, Weimar C, Rueckert CM, Thijs V, Kappelle LJ, Schonewille WJ, Basilar Artery International Cooperation Study Group: Time is brain(stem) in basilar artery occlusion. Stroke 2012; 43: 3003-3006.
31. Song SS, Latour LL, Ritter CH, Wu O, Tighiouart M, Hernandez DA, Ku KD, Luby M, Warach S: A pragmatic approach using magnetic resonance imaging to treat ischemic strokes of unknown onset time in a thrombolytic trial. Stroke 2012; 43: 2331-2335.
32. Pedraza S, Puig J, Blasco G, Daunis-i-Estadella J, Boada I, Bardera A, Prats A, Castellanos M, Serena J: Magnetic resonance imaging biomarkers of ischemic stroke: Criteria for the validation of primary imaging biomarkers. Drug News Perspect 2009; 22: 481-486.
33. Leiva-Salinas C, Hom J, Warach S, Wintermark M: Stroke imaging research road map. Neuroimag Clin N Am 2011; 21: 239-245, ix.